Letko, Brosseau & Associates’s Illumina ILMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$146M Sell
830,293
-22,610
-3% -$3.31M 2.16% 14
2026
Q1
$105M Sell
852,903
-6,090
-0.7% -$800K 1.69% 20
2025
Q4
$113M Buy
858,993
+4,675
+0.5% +$549K 1.84% 16
2025
Q3
$81.1M Buy
854,318
+750
+0.1% +$74.4K 1.39% 26
2025
Q2
$81.4M Buy
853,568
+9,470
+1% +$769K 1.56% 24
2025
Q1
$67M Buy
844,098
+158,325
+23% +$17.1M 1.42% 29
2024
Q4
$91.6M Sell
685,773
-1,932
-0.3% -$275K 1.77% 19
2024
Q3
$89.7M Buy
+687,705
New +$84.8M 1.63% 22

Other funds holding ILMN

Letko, Brosseau & Associates's ILMN Position: Q2 2026 in Review

Letko, Brosseau & Associates reduced its Illumina (ILMN) stake by 2.7% in Q2 2026, selling an estimated $3.31M and leaving 830,293 shares worth $146M. The position accounts for 2.16% of the portfolio, ranked #14.

Letko, Brosseau & Associates first reported a position in ILMN in Q3 2024 and has held it in 8 quarters since. 935 funds tracked by Wall St. Rank hold ILMN as of Q2 2026.

  • Letko, Brosseau & Associates held 830,293 shares of Illumina worth $146M as of Q2 2026.
  • Letko, Brosseau & Associates sold 22,610 Illumina shares in Q2 2026, an estimated $3.31M.
  • Illumina made up 2.16% of Letko, Brosseau & Associates's portfolio in Q2 2026, its #14 holding.
  • Letko, Brosseau & Associates first reported a position in Illumina in Q3 2024 and has held it in 8 quarters since.
  • 935 funds tracked by Wall St. Rank held Illumina as of Q2 2026.

Based on Letko, Brosseau & Associates's 13F filing for Q2 2026, filed 13 Aug 2026.